Status:
COMPLETED
Sickle Cell Anemia Screening and Prevention in Northern Israel
Lead Sponsor:
HaEmek Medical Center, Israel
Collaborating Sponsors:
Ministry of Health, Israel
Conditions:
Thalassemia
Sickle Cell Anemia
Eligibility:
All Genders
18+ years
Brief Summary
Since 1987, a screening for β Thalassemia in pregnant women is carried on in northern Israel, and from 1999 all the samples were tested also for Hgb S, Hgb C, Hgb D, Hgb O Arab and others. In this st...
Eligibility Criteria
Inclusion
- All pregnant women tested and their husband in those cases that the woman test revealed abnormal hemoglobin.
Exclusion
- No exclusion criteria.
Key Trial Info
Start Date :
May 1 2008
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
March 1 2009
Estimated Enrollment :
69 Patients enrolled
Trial Details
Trial ID
NCT00735488
Start Date
May 1 2008
End Date
March 1 2009
Last Update
September 1 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Pediatric Hematology Unit - Ha'Emek Medical Center
Afula, Afula, Israel, 18101